From: Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
Positive antigen avoidance test | n | delta FVC %pred (%) |
---|---|---|
With treatment | 7 | 0.4 ± 2.3 |
Without treatment | 8 | 1.1 ± 2.1 |
Negative antigen avoidance test | n | delta FVC %pred (%) |
---|---|---|
With treatment | 11 | − 3.0 ± 2.2 |
Without treatment | 9 | − 7.5 ± 4.7 |